Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Organisation › Details

Graph Therapeutics FlexCo (AT)

https://www.graphtx.com

LinkedIn: https://www.linkedin.com/company/graphtx

	Start	2024-06-28 established
	Industry	BIOTECH
	Industry 2	AI-based drug discovery / AI-based drug development
	Person	Vladimer, Gregory (Graph Therapeutics 202501 CEO + Co-Founder before AllCyte)
	Person 2	Sehlke, Robert (Graph Therapeutics 202501 CTO + Co-Founder before Allcyte)

	Region	Klosterneuburg
	Country	Austria
	Street	1 Plöcking Xista Sience Park
	City	3400 Klosterneuburg
		Address record changed: 2025-01-13

Basic data	Employees	n. a.


		Record changed: 2025-03-16

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

More documents for Graph Therapeutics FlexCo (AT)

[1] Graph Therapeutics FlexCo. (1/9/25). "Press Release: Graph Therapeutics Raises $3.1M Pre-Seed Round to Transform Drug Discovery for Immunological Diseases". Vienna....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)